In the early hours at Al Jalila Children's Hospital, a touching narrative of hope comes to life, centered around young Anas Mohamed Allam from Egypt. Anas is bravely confronting Duchenne muscular dystrophy, with his parents steadfastly by his side. Their presence is not just about supporting his treatment but also about providing a foundation of courage and comfort as they navigate this challenging battle against a disease that slowly weakens his muscles, diminishing his mobility day by day.
Duchenne muscular dystrophy is a neuromuscular condition caused by a defect in the dystrophin protein, leading to a gradual decline in muscle function. To fight this disease, Anas received Elevides, one of the globe's priciest treatments at Dhs10.6 million. This advanced gene therapy involves a single intravenous session that introduces a functional version of the dystrophin gene directly into the patient's cells.
The treatment aids the body in producing a crucial protein, which fortifies muscles and decelerates disease progression, thereby enhancing the quality of life for those affected. Research suggests that this disorder predominantly affects males, with an occurrence in one out of every 3,500 to 5,000 male births globally, while it is extremely rare in females. As the disease advances, individuals often lose their ability to walk, and their upper limb functions, as well as lung and heart capacity, become compromised. The average life expectancy for those affected is around 30 years.
Yes, I Will Live
A young boy, weakened by illness, faces a monumental challenge while his family grapples with anxiety and stress, fighting a real battle against time to secure vital treatment. The expense of the gene therapy injection posed a significant barrier to accessing it. Throughout his sickness, his simple desire was to live, until his resolve strengthened with the words, “Yes, I will live,” after receiving the injection and feeling reassured about his recovery.
Anas Triumphs Through Hope
Following the publication of Anas's story by Al Khaleej newspaper, a flicker of hope emerged in his life. Generous donors succeeded in raising 4 million dirhams towards the treatment costs. Additionally, a benefactor, through the "Pain and Hope" program on Sharjah TV, committed to covering the remaining 6 million dirhams. This generous act effectively concluded a prolonged journey of suffering and anticipation for Anas and his family.
A Long-Awaited Moment
With the funds for treatment finally raised, Anas and his family reached the moment they had long dreamed of: receiving the gene therapy injection after a challenging journey.
Following the injection, Anas's father expressed deep gratitude to everyone who supported them through their ordeal.
He revealed the family's state of constant anxiety and anticipation, particularly as Anas reached this stage in life.
He remarked that the generous donation of the remaining funds marked a crucial turning point for the family. The initiative ended a long period of fear and waiting, offering Anas a renewed chance to combat his illness.